Search for: "PFIZER PHARMACEUTICALS" Results 81 - 100 of 1,413
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
11 Nov 2021, 8:32 am by Tim De Chant
He was impressed that the company had contracts with a number of pharmaceutical companies, including Pfizer and Novartis, and believed in its mission. [read post]
8 Nov 2021, 6:42 am by John Jascob
In that matter, an employee at a pharmaceutical company called Medivation traded on inside information that the company would be acquired by Pfizer. [read post]
4 Nov 2021, 7:03 pm by Edward T. Kang and Ryan T. Kirk
This trend is particularly evident in the pharmaceutical sector, where violations of the FCA have forced corporate behemoths like GlaxoSmithKline and Pfizer into billion-dollar settlements. [read post]
29 Oct 2021, 6:05 am by Robert Kraft
Finance, Pfizer CEO Albert Bourla discussed drug pricing with Anjalee Khemlani. [read post]
21 Oct 2021, 9:03 pm by Jillian Moss
Kaplan stated that loosening these kinds of standards may lead to insufficient awareness of pharmaceutical side effects from patients. [read post]
15 Oct 2021, 2:00 am by vrose
The pharmaceutical company Pfizer operated out of a modest red-brick building located at the intersection of Harrison Avenue and Bartlett Street in the Broadway Triangle neighborhood of Williamsburg, Brooklyn until Pfizer relocated in 2007. [read post]
1 Oct 2021, 5:54 am by greggshapiro.admin
In a 32-page decision issued late yesterday, Southern District of New York Judge Mary Kay Vyskocil granted summary judgment for the government in a case where pharmaceutical giant Pfizer challenged an HHS-OIG Advisory Opinion finding that Pfizer could violate the anti-kickback statute (AKS) if it went ahead with a proposal to provide co-pay assistance for an expensive drug covered by Medicare Part D. [read post]
29 Sep 2021, 1:15 pm by Tom Lamb
At the present time, our law firm is investigating Xeljanz lawsuits filed against Pfizer, the pharmaceutical company responsible for Xeljanz, for patients with cases of Xeljanz causing heart problems such as heart attacks, strokes, pulmonary embolism (PE), and deep vein thrombosis (DVT), as well as Xeljanz causing lymphoma, lung cancer, and other cancers. [read post]
23 Sep 2021, 2:10 am by Rose Hughes
The US Courts of Appeal of the Federal Circuit (CAFC) found in Belcher Pharmaceuticals v Hospira, Inc that a formulation patent was unenforceable in view of inequitable conduct, in the form of contradictory submissions to the patent office and the regulatory agency (FDA) by the patentee. [read post]
14 Sep 2021, 1:54 pm by Doug Cornelius
Panuwat learned from Medivation’s CEO that the company expected to be acquired by a major pharmaceutical company, Pfizer, within a few days, at a premium to the then-market price. [read post]
9 Sep 2021, 10:03 am by Lebowitz & Mzhen
Pharmaceutical drugs are intended to treat serious illnesses and conditions. [read post]
1 Sep 2021, 12:45 pm by Tom Lamb
However, this September 2021 FDA regulatory action regarding Xeljanz is not altogether unexpected, as can be seen by these five Drug Injury Watch articles about Xeljanz drug safety developments which we wrote earlier this year: Possible FDA Advisory Committee Meeting for Xeljanz, Rinvoq, and Other Janus Kinase (JAK) Inhibitors  (July 6, 2021) Xeljanz and Other JAK Inhibitors: Drug Safety Concerns Indicated by Recent FDA Actions  (April 15, 2021) Possible Ramifications of Recent FDA Alert… [read post]
26 Aug 2021, 9:03 pm by Jillian Moss
The change in language comes after FDA approved the Pfizer vaccine earlier this week. [read post]
23 Aug 2021, 2:12 am by Radhi Shah (USC Gould School of Law)
Their request was based on Pfizer’s glaucoma drug being sold in the U.S. at prices two to five times the prices in other high income countries. [read post]
22 Aug 2021, 6:00 pm by Juvan Bonni
 Jie Fei (Christina) Pan: Federal Court of Appeal upholds decision finding Seedling’s LifeCard patent invalid and not infringed by Pfizer’s EpiPen (Source: JD Supra) Atty. [read post]
17 Aug 2021, 7:20 am by Mark Astarita
The Securities and Exchange Commission today charged a former employee of California-based Medivation Inc. with insider trading in advance of Medivation's announcement that it would be acquired by pharmaceutical giant Pfizer Inc. [read post]